CD8 + T Cell Infiltration Elicits Molecular Subtype‐Biased Clinical Outcomes in Gastric Cancer Patients
Cancer Science · 2026-05 · 117 (5) · 1434-1445
DOI: 10.1111/cas.70366 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, online erschienen am 20.03.2026. Verfasst von Zhen Ling und 9 weiteren Autor:innen. Beteiligte Einrichtung: National Health Commission Key Laboratory of Glycoconjugate Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Scien…. Hauptthemen laut MEDLINE: Stomach Neoplasms, CD8-Positive T-Lymphocytes, Lymphocytes, Tumor-Infiltrating. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Natural Science Foundation of Fujian Province, Shanghai Municipal Health Commission, National Natural Science Foundation of China.
Themen: Onkologische Pflege
Abstract (Originalsprache)
CD8 + T cell infiltration is essential for antitumor immunity across cancers while its clinical significance in gastric cancer (GC) remains unclear. This reflects molecular heterogeneity of GC, as defined by The Cancer Genome Atlas (TCGA) into four subtypes: Epstein–Barr virus (EBV)‐positive, microsatellite instability (MSI), chromosomal instability (CIN), and genomically stable (GS), each with distinct immune features. We aimed to characterize distribution, clinical relevance, and immune associations of CD8 + T cell infiltration within this molecular framework. TCGA ( n = 336) and Zhongshan Hospital (ZSHS, n = 455) cohorts were analyzed. CD8 + T cell infiltration and immune features were compared across TCGA subtypes. Prognostic and predictive significance of CD8 + T cells was evaluated in ZSHS cohort. CD8 + T cell infiltration was elevated in the EBV‐positive and MSI subtypes (ZSHS: p = 0.026; TCGA: p < 0.001). In ZSHS cohort, high CD8 + T cell infiltration was associated with better overall survival ( p = 0.040), particularly in the EBV‐positive ( p = 0.036) and CIN ( p = 0.065) subtypes, but not in MSI ( p = 0.440) or GS ( p = 0.860). Notably, low CD8 + T infiltration predicted superior response to adjuvant chemotherapy in MSI patients (HR = 0.210, p = 0.022). Immune profiling revealed associations of CD8 + T cells with antigen presentation in EBV‐positive, tertiary lymphoid structure signatures in CIN, and podoplanin+ cells in GS tumors, instead of neoantigen burden in MSI or pan‐fibroblast TGFβ response signature in GS. CD8 + T cell infiltration demonstrates subtype‐specific prognostic and therapeutic significance in GC—beneficial in EBV‐positive and CIN tumors, and predictive of chemotherapy response in MSI with low infiltration, which accompanied by divergent immune features, reflecting heterogeneous immunological landscape of GC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Health Commission Key Laboratory of Glycoconjugate Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
- Department of Endoscopy, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
- Department of Gastrointestinal Surgery, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Oncology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Acute Care Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
- Department of Gastrointestinal Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
ORCID-Profile: Zhen Ling, Jieti Wang, Yun Gu, Ziqiu Zhang, Fei Shao, Chao Lin, Hongyong He, Ruochen Li, Hao Liu, Jiejie Xu
Förderung
- Natural Science Foundation of Fujian Province
- Shanghai Municipal Health Commission
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Shanghai Pujiang Talents Program
- Natural Science Foundation of Shanghai Municipality
- Clinical Research Fund of Zhongshan Hospital Fudan University
- Development Foundation and Shanghai Municipal Education Commission
Zitieren
APA
Ling, Z., Wang, J., Gu, Y., Zhang, Z., Shao, F., Lin, C., He, H., Li, R., Liu, H., & Xu, J. (2026). CD8 + T Cell Infiltration Elicits Molecular Subtype‐Biased Clinical Outcomes in Gastric Cancer Patients. Cancer Science, 117(5), 1434-1445. https://doi.org/10.1111/cas.70366
Vancouver
Ling Z, Wang J, Gu Y, Zhang Z, Shao F, Lin C, et al. CD8 + T Cell Infiltration Elicits Molecular Subtype‐Biased Clinical Outcomes in Gastric Cancer Patients. Cancer Science. 2026;117(5):1434-1445. doi:10.1111/cas.70366
BibTeX
@article{Ling2026,
author = {Ling, Zhen and Wang, Jieti and Gu, Yun and Zhang, Ziqiu and Shao, Fei and Lin, Chao and He, Hongyong and Li, Ruochen and Liu, Hao and Xu, Jiejie},
title = {CD8 + T Cell Infiltration Elicits Molecular Subtype‐Biased Clinical Outcomes in Gastric Cancer Patients},
journal = {Cancer Science},
year = {2026},
volume = {117},
number = {5},
pages = {1434--1445},
doi = {10.1111/cas.70366}
}
EUVIMED